Opioids may help some patients suffering neuropathic pain, but do not help with mobility and function, according to researchers.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
A clinical trial using cholesterol-lowering treatment Simvastatin in people living with Parkinson’s is getting underway in centers across England — with the hope that it could become one of a number of effective treatments available to treat Parkinson’s.
Recent evidence has shown a greater risk of dementia, in particular Alzheimer’s disease (AD), in individuals using anticholinergic medications regularly. These drugs are widely used by older adults to treat bladder dysfunction, mood, and pain, and many of them are available without prescription. Since these drugs are often used to treat both motor symptoms and non-motor symptoms in patients with Parkinson’s Disease (PD), there is concern for increased risk of dementia. Contrary to expectations, a study has determined that the cognitive performance of PD patients taking anticholinergic medications did not differ from those who did not.